Retinal Disease Therapeutics Market 2019 Global Industry Size, Share, Growth, Sales and Drivers Analysis Research Report 2026

Retinal Disease Therapeutics Industry 2019 Global Market research Fortune Business Insights report provides key analysis on the market status of the Retinal Disease Therapeutics manufacturers with market size, growth, share, trends

Pune, India - July 5, 2019 /MarketersMedia/ —

The Global Retinal Disease Therapeutics Market is likely to expand at an impressive rate driven by recent government participation towards the prevention and control of retinal diseases. According to a report published by Fortune Business Insights, titled “Retinal Disease Therapeutics: Global Market Analysis, Insights, and Forecast, 2019-2026,” the market is likely to reach US$ 21,318.0 Mn by the end of 2026. The market was valued at US$ 11,044.2 Mn in 2018 and is likely to witness a CAGR of 8.6% in the forecast period.

Browse Complete Report Details:
https://www.fortunebusinessinsights.com/industry-reports/retinal-disease-therapeutics-market-100311

The Global Retinal Disease Therapeutics Market is consolidated in nature, with only a handful of market players accounting for the maximum share of the market. With consolidation, it is becoming increasingly difficult for newer market entrants to establish a stronghold or derive immediate success. Therefore the global market is boosted by products and concepts introduced by existing companies.

Some of the Main Key Players Covered in the Report

• Merck
• Novartis
• Allergan
• Roche
• Regeneron Pharmaceuticals, Inc.
• Santen Pharmaceutical

F. Hoffmann-La Roche AG’s ‘Lucentis’ is Gaining Increasing Popularity

The diabetic retinopathy is a severe kind of disorder that has accounted for the majority of cases of blindness in the US. Lucentis was an instant hit among healthcare professionals after it was backed by a series of clinical trials and approvals from the National Institute of Health (NIH).

One such instance of this development is the “Lucentis” therapy, put forward by F. Hoffmann-La Roche AG. Lucentis was introduced to provide therapeutic advice and development of products for patients suffering from chronic disease. In 2017, the Food and Drug Administration (FDA) approved Lucentis for diabetic retinopathy.

Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/retinal-disease-therapeutics-market-100311

Excellent clinical effects of Lucentis have led to a subsequent rise in demand for medicine among patients. The increasing demand has contributed to the growth of the global retinal disease therapeutics market and is likely to favor the market in the forthcoming years.

Segmentation:

By Disease Indication
• Macular Degeneration
• Diabetic Retinopathy
• Diabetic Macular Edema
• Retinal Vein Occlusion

By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy

By Geography
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Recent industry developments such as mergers & acquisitions
4.2 Regulatory scenario for key countries
4.3 Prevalence of Key RetinalDiseases, in Major Countries
5. Global RetinalDisease Therapeutics Market Analysis, Insights, and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2 Market Analysis, Insights andForecast – By Disease Indication
5.2.1 macular degeneration
5.2.2 DiabeticMacular Edema
5.2.3 diabetic retinopathy
5.2.4 retinal vein Occlusion
5.2.5 Others
5.3. Market Analysis, Insights and Forecast – By End User
5.3.1 hospital pharmacy
5.3.2 retail pharmacy
5.3.3 Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1 NorthAmerica
5.4.2 Europe
5.4.3 AsiaPacific
5.4.4 Latin America
5.4.5 MiddleEast & Africa

North America to Emerge Dominant in the Forecast Period

The increasing government investment towards research and development of retinal disease drugs and diagnostic devices is enabling growth in the retinal diseases therapeutics market in North America. North America has emerged dominant in the global retinal disease therapeutics market in recent years. The Retinal Disease Therapeutics Market in North America was valued at US$ 4056.5Mn in 2018 and is likely to increase in the coming years.

Improved health infrastructures, increasing patient pool, and favorable health reimbursement policies are some of the factors that are likely to boost the regional market in the forthcoming years. High prevalence of retinal diseases in the Asia Pacific is a major reason why this region is estimated to rise with the highest CAGR in the forecast period.

Speak to Analyst:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/retinal-disease-therapeutics-market-100311

About Us:

Fortune Business Insights offers expert corporate ANALYSIS and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Mr. Ashwin Arora
Email: Send Email
Organization: Fortune Business Insights Pvt. Ltd
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/retinal-disease-therapeutics-market-2019-global-industry-size-share-growth-sales-and-drivers-analysis-research-report-2026/88892952

Source: MarketersMedia

Release ID: 88892952